How AbbVie Could Hammer Gilead's Hepatitis C Franchise Submitted by admin on Wed, 07/19/2017 - 19:55 Read more about How AbbVie Could Hammer Gilead's Hepatitis C Franchise Source Investors Business Daily Headline How AbbVie Could Hammer Gilead's Hepatitis C Franchise News Tags AbbVie Gilead Sciences hepatitis C Vosevi Harvoni Sovaldi Epclusa Viekira Pak
3 Biggest Risks for AbbVie in 2017 Submitted by admin on Wed, 12/28/2016 - 11:03 Read more about 3 Biggest Risks for AbbVie in 2017 Source Motley Fool Headline 3 Biggest Risks for AbbVie in 2017 News Tags AbbVie Humira biosimilars Imbruvica Viekira Pak Elagolix risankizumab
3 Things AbbVie's Management Said While Its Stock Got Hammered Submitted by admin on Sat, 10/29/2016 - 13:23 Read more about 3 Things AbbVie's Management Said While Its Stock Got Hammered Source Motley Fool Headline 3 Things AbbVie's Management Said While Its Stock Got Hammered News Tags AbbVie earnings Humira Imbruvica Viekira Pak
AbbVie's Viekira Pak Sales Plummet in Q3 Submitted by admin on Fri, 10/28/2016 - 17:22 Read more about AbbVie's Viekira Pak Sales Plummet in Q3 Source Motley Fool Headline AbbVie's Viekira Pak Sales Plummet in Q3 News Tags AbbVie Viekira Pak eanrings
AbbVie Inc: New Drugs May Overcome Humira Loss Submitted by admin on Mon, 08/01/2016 - 15:56 Read more about AbbVie Inc: New Drugs May Overcome Humira Loss Source Bidness, ETC Headline AbbVie Inc: New Drugs May Overcome Humira Loss News Tags AbbVie Humira Rova-T Venclexta Imbruvica Viekira Pak
AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAKwithout Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis Submitted by admin on Mon, 04/25/2016 - 18:39 Read more about AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAKwithout Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis Source Yahoo Headline AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEK… News Tags AbbVie FDA Viekira Pak hepatitis C
Will Merck Encroach On Gilead's Harvoni Territory? Submitted by admin on Tue, 02/23/2016 - 17:44 Read more about Will Merck Encroach On Gilead's Harvoni Territory? Source Yahoo/Benzinga Headline Will Merck Encroach On Gilead's Harvoni Territory? News Tags Merck Gilead Harvoni AbbVie hepatitis C Viekira Pak Zepatier
Harvoni’s New Label Gives Gilead Edge Over AbbVie Submitted by admin on Wed, 02/17/2016 - 10:42 Read more about Harvoni’s New Label Gives Gilead Edge Over AbbVie Source Bidness, ETC Headline Harvoni’s New Label Gives Gilead Edge Over AbbVie News Tags Harvoni labeling Gilead Sciences AbbVie Viekira Pak hepatitis C
3 Slides That Perfectly Sum Up Where AbbVie Is Headed Next Submitted by admin on Tue, 01/19/2016 - 16:24 Read more about 3 Slides That Perfectly Sum Up Where AbbVie Is Headed Next Source Motley Fool Headline 3 Slides That Perfectly Sum Up Where AbbVie Is Headed Next News Tags AbbVie Humira Imbruvica Viekira Pak
AbbVie Is Expected to Strengthen Its Position in Virology in 4Q15 Submitted by admin on Tue, 01/19/2016 - 09:28 Read more about AbbVie Is Expected to Strengthen Its Position in Virology in 4Q15 Source Yahoo/Market Realist Headline AbbVie Is Expected to Strengthen Its Position in Virology in 4Q15 News Tags AbbVie hepatitis C Lupron Duodopa Creon Viekira Pak